Redmile Group, LLC
- SEC CIK
- 0001425738
In the past year, 1 open-market purchase filing worth $10.2M and 1 sale filing worth $19.6M.
Current role at each company
- ATTO Attovia Therapeutics, Inc.10% Owneras of Aug 7, 2026
- ATRA Atara Biotherapeutics, Inc.Directoras of Jul 24, 2026
- FATE Fate Therapeutics IncDirector, 10% Owneras of Jun 15, 2026
- ADCT ADC Therapeutics SA10% Owneras of Apr 2, 2026
- STTK Shattuck Labs, Inc.Director, 10% Owneras of Aug 26, 2025
Show 9 more companies
- IGMS IGM Biosciences, Inc.Director, 10% Owneras of Aug 15, 2025
- AUGX Augmedix, Inc.Director, 10% Owneras of Oct 4, 2024
- ABSI Absci CorpDirectoras of Jun 14, 2024
- SNCE Science 37 Holdings, Inc.Other: Former 10% Owner and Directoras of Mar 13, 2024
- RYZB RayzeBio, Inc.10% Owneras of Sep 21, 2023
- MDVL MedAvail Holdings, Inc.Director, 10% Owneras of Jun 21, 2023
- ZYME Zymeworks Inc.10% Owneras of Oct 18, 2022
- TRDA Entrada Therapeutics, Inc.10% Owneras of Nov 4, 2021
- IVVD Invivyd, Inc.10% Owneras of Aug 12, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $10.2M
- 1 filing
- Sold
- $19.6M
- 1 filing
- Net
- −$9.44M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Redmile Group, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATTO Attovia Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)9:47 PM ET | Aug 6 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchase | +200.0K | $17.00 | +$3.40M | +25.5%982.9K after | |
| Aug 7, 2026 (view filing)9:47 PM ET | Aug 6 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchase | +400.0K | $17.00 | +$6.80M | +51.1%1.18M after |
ADCT ADC Therapeutics SA
10% Owner15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 (view filing)9:00 PM ET | Mar 31-Apr 2 | 2 days | Redmile Group, LLC and 2 others10% Owner | SSale | −3.00M | $3.34 | −$10.0M | −19.1%12.7M after | 3 lots |
| Apr 2, 2026 (view filing)9:00 PM ET | Mar 31-Apr 2 | 2 days | Redmile Group, LLC and 2 others10% Owner | SSale | −2.88M | $3.34 | −$9.62M | −21.9%10.3M after | 3 lots |
| Oct 28, 2025 (view filing)9:00 PM ET | Oct 27 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Share | +3.85M | $3.90 | +$15.0M | –3.85M after | Derivative |
| Oct 28, 2025 (view filing)9:00 PM ET | Oct 27 | 1 day | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Share | +3.85M | $3.90 | +$15.0M | –3.85M after | Derivative |
| Jun 13, 2025 (view filing)6:00 PM ET | Jun 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Share | +15.7M | $3.43 | +$54.0M | –15.7M after | Derivative |
| Jun 13, 2025 (view filing)6:00 PM ET | Jun 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Share | +12.5M | $3.43 | +$42.8M | –12.5M after | Derivative |
| Dec 13, 2024 (view filing)9:00 PM ET | Dec 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +100.0K | $3.05 | +$304.5K | +0.6%15.7M after | 2 lots |
| Dec 13, 2024 (view filing)9:00 PM ET | Dec 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +100.0K | $3.05 | +$304.5K | +0.8%13.1M after | 2 lots |
| Dec 6, 2024 (view filing)9:00 PM ET | Dec 4 | 2 days | Redmile Group, LLC and 2 others10% Owner | SSaleCommon Shares, par value CHF 0.08 per share | −25.4K | $2.07 | −$52.5K | −0.2%15.6M after | |
| Jul 3, 2024 (view filing)8:00 PM ET | Jul 1 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +400.0K | $2.81 | +$1.12M | +2.6%15.7M after |
FATE Fate Therapeutics Inc
Director, 10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 (view filing)9:00 PM ET | Dec 20 | 6 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | SSale | −341.6K | $1.68 | −$573.9K | −2.7%12.5M after | |
| Dec 26, 2024 (view filing)9:00 PM ET | Dec 20 | 6 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +398.0K | $1.68 | +$668.6K | +3.2%12.9M after | |
| Dec 28, 2023 (view filing)9:30 PM ET | Dec 26 | 2 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +44.6K | $3.72 | +$166.0K | +0.3%13.2M after | |
| Apr 21, 2023 (view filing)9:55 PM ET | Apr 20-21 | 1 day | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +276.6K | $6.17 | +$1.71M | +2.2%13.1M after | 2 lots |
| Apr 17, 2023 (view filing)9:30 PM ET | Apr 14 | 3 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | SSale | −302.3K | $5.84 | −$1.77M | −2.3%12.8M after | |
| Apr 17, 2023 (view filing)9:30 PM ET | Apr 14 | 3 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +25.7K | $6.00 | +$154.2K | +0.2%12.9M after |
STTK Shattuck Labs, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 (view filing)9:00 PM ET | Dec 4 | 2 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | SSaleCommon Stock, par value $0.0001 per share | −133.4K | $1.25 | −$166.7K | −2.4%5.41M after | |
| Dec 6, 2024 (view filing)9:00 PM ET | Dec 4 | 2 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +133.4K | $1.25 | +$166.7K | +2.5%5.54M after |
ABSI Absci Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 (view filing)9:30 PM ET | Mar 1 | 4 days | Redmile Group, LLC and 1 otherDirector | PPurchase | +222.2K | $4.50 | +$1.00M | +2.8%8.25M after | |
| Jul 28, 2021 (view filing)9:01 PM ET | Jul 26 | 2 days | Redmile Group, LLC and 1 otherDirector | PPurchase | +1.88M | $16.00 | +$30.0M | +30.5%8.03M after |
AUGX Augmedix, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 (view filing)4:15 PM ET | Nov 20 | 2 days | Redmile Group, LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $4.00 | +$3.00M | +4.8%16.4M after | |
| Nov 22, 2023 (view filing)4:15 PM ET | Nov 20 | 2 days | Redmile Group, LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $4.00 | +$3.00M | +8.6%9.45M after | |
| Apr 21, 2023 (view filing)9:53 PM ET | Oct 28, 2021 | 540 days | Redmile Group, LLC and 2 othersDirector, 10% Owner | PPurchase | +1.63M | $4.00 | +$6.50M | +35.4%6.22M after | Amended |
| Nov 1, 2021 (view filing)9:00 PM ET | Oct 28 | 4 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +1.63M | $4.00 | +$6.50M | +12.7%14.4M after |
IGMS IGM Biosciences, Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 (view filing)9:45 PM ET | Jun 29 | 4 days | Redmile Group, LLC and 1 otherDirector | SSale | −80.4K | $9.42 | −$757.6K | −2.7%2.89M after | |
| Jul 3, 2023 (view filing)9:45 PM ET | Jun 29 | 4 days | Redmile Group, LLC and 1 otherDirector | PPurchase | +80.4K | $9.42 | +$757.6K | +2.8%2.97M after | |
| Apr 4, 2022 (view filing)9:45 PM ET | Apr 1 | 3 days | Redmile Group, LLC and 1 otherDirector, 10% Owner | PPurchase | +2.61M | $23.00 | +$60.0M | –4.50M after | Derivative |
ZYME Zymeworks Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2022 (view filing)6:07 AM ET | Oct 13 | 5 days | Redmile Group, LLC and 1 other10% Owner | PPurchaseCommon Stock, par value $0.00001 per share | +30.5K | $5.03 | +$153.4K | +0.5%6.08M after | Amended |
TRDA Entrada Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 (view filing)9:00 PM ET | Nov 2 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchase | +1.00M | $20.00 | +$20.0M | +104.8%1.95M after |
IVVD Invivyd, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 (view filing)9:01 PM ET | Aug 10 | 2 days | Redmile Group, LLC and 1 other10% Owner | PPurchase | +1.47M | $17.00 | +$25.0M | +76.5%3.39M after |